Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Atkinson

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Investigation|February 5, 2019
Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in miceKate Smith-Jackson, Yi Yang, Harriet Denton, et al.
The EMBO Journal|March 26, 2016
Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding modeFederico Forneris, Jin Wu, Xiaoguang Xue, et al.
Blood|April 23, 2010
Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formationSergei Zaitsev, Dirk Spitzer, Juan-Carlos Murciano, et al.
Ebiomedicine|October 28, 2018
Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trialsSoumi Gupta, Kelly Lau, Cary O Harding, et al.
The Journal of Biological Chemistry|November 12, 2013
Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptorHyon Ju Park, Mara Guariento, Mateusz Maciejewski, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2009
Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysisSergei Zaitsev, Sergei Zaitzev, Dirk Spitzer, et al.
Journal of Autoimmunity|December 23, 2008
Hepatic IL-17 responses in human and murine primary biliary cirrhosisRuth Y Z Lan, Thucydides L Salunga, Koichi Tsuneyama, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2003
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndromeAnna Richards, Elizabeth J Kemp, M Kathryn Liszewski, et al.
Journal of the American Society of Nephrology : JASN|June 10, 2006
Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndromeVéronique Fremeaux-Bacchi, Elizabeth A Moulton, David Kavanagh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Antibody directs properdin-dependent activation of the complement alternative pathway in a mouse model of abdominal aortic aneurysmHui-Fang Zhou, Huimin Yan, Cordula M Stover, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Investigation|February 5, 2019
Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in miceKate Smith-Jackson, Yi Yang, Harriet Denton, et al.
The EMBO Journal|March 26, 2016
Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding modeFederico Forneris, Jin Wu, Xiaoguang Xue, et al.
Blood|April 23, 2010
Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formationSergei Zaitsev, Dirk Spitzer, Juan-Carlos Murciano, et al.
Ebiomedicine|October 28, 2018
Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trialsSoumi Gupta, Kelly Lau, Cary O Harding, et al.
The Journal of Biological Chemistry|November 12, 2013
Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptorHyon Ju Park, Mara Guariento, Mateusz Maciejewski, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2009
Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysisSergei Zaitsev, Sergei Zaitzev, Dirk Spitzer, et al.
Journal of Autoimmunity|December 23, 2008
Hepatic IL-17 responses in human and murine primary biliary cirrhosisRuth Y Z Lan, Thucydides L Salunga, Koichi Tsuneyama, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2003
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndromeAnna Richards, Elizabeth J Kemp, M Kathryn Liszewski, et al.
Journal of the American Society of Nephrology : JASN|June 10, 2006
Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndromeVéronique Fremeaux-Bacchi, Elizabeth A Moulton, David Kavanagh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Antibody directs properdin-dependent activation of the complement alternative pathway in a mouse model of abdominal aortic aneurysmHui-Fang Zhou, Huimin Yan, Cordula M Stover, et al.
Pageof 20